Bank of New York Mellon Corp

Bank

Position in OBIO — Orchestra BioMed Holdings, Inc.

CIK 1390777 NEW YORK, NY

Position in OBIO

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$371,533

+$146,876 QoQ

Shares Held

86,103

+64.0% QoQ

Ownership

0.143%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#24

of 77 holders

Holding Since

Jun 2023

9 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. OBIO ranks #263 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,672,623	$830,842,010
2	REGN	Regeneron Pharmaceuticals, Inc.	758,492	$472,950,091
3	JAZZ	Jazz Pharmaceuticals plc	1,578,013	$380,253,782
4	ALNY	Alnylam Pharmaceuticals, Inc.	492,071	$148,128,128
5	INSM	INSMED Inc	1,312,756	$139,966,036
6	MRNA	Moderna, Inc.	1,701,675	$119,168,293
7	RVMD	Revolution Medicines, Inc.	601,056	$112,565,759
8	INCY	Incyte Corp	972,825	$110,279,435

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$371,533	86,103	+64.0%	Shares	Defined	2026-08-06
2025-03-31	$224,657	52,490	-0.6%	Shares	Defined	2025-04-29
2024-12-31	$211,220	52,805	+0.6%	Shares	Defined	2025-02-04
2024-09-30	$269,798	52,490	-25.7%	Shares	Defined	2024-11-12
2024-06-30	$576,057	70,682	+115.7%	Shares	Defined	2024-07-25
2024-03-31	$172,729	32,776	-30.6%	Shares	Defined	2024-04-25
2023-12-31	$431,209	47,230	+17.2%	Shares	Defined	2024-01-29
2023-09-30	$351,328	40,290	+211.2%	Shares	Defined	2023-10-24
2023-06-30	$90,622	12,946	—	Shares	Defined	2023-08-03
No filing history on record for this holder in this stock.